KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Receivables - Other: 2012-2024

Historic Receivables - Other for TherapeuticsMD (TXMD) over the last 6 years, with Dec 2024 value amounting to $3.6 million.

  • TherapeuticsMD's Receivables - Other rose 10.29% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 10.29%. This contributed to the annual value of $3.6 million for FY2024, which is 83.49% down from last year.
  • TherapeuticsMD's Receivables - Other amounted to $3.6 million in FY2024, which was down 83.49% from $21.6 million recorded in FY2023.
  • TherapeuticsMD's 5-year Receivables - Other high stood at $21.6 million for FY2023, and its period low was $3.6 million during FY2024.
  • Moreover, its 2-year median value for Receivables - Other was $12.6 million (2023), whereas its average is $12.6 million.
  • Data for TherapeuticsMD's Receivables - Other shows a maximum YoY slumped of 83.49% (in 2024) over the last 5 years.
  • Over the past 2 years, TherapeuticsMD's Receivables - Other (Yearly) stood at $21.6 million in 2023, then tumbled by 83.49% to $3.6 million in 2024.